Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

2QLR

Crystal structure of human kynurenine aminotransferase II

Summary for 2QLR
Entry DOI10.2210/pdb2qlr/pdb
DescriptorKynurenine/alpha-aminoadipate aminotransferase mitochondrial, GLYCEROL (3 entities in total)
Functional Keywordsalpha & beta protein, plp-dependent transferase, aminotransferase, mitochondrion, multifunctional enzyme, pyridoxal phosphate, transit peptide, transferase
Biological sourceHomo sapiens (human)
Cellular locationMitochondrion (Potential): Q8N5Z0
Total number of polymer chains4
Total formula weight191619.33
Authors
Han, Q.,Robinson, R.,Li, J. (deposition date: 2007-07-13, release date: 2007-12-04, Last modification date: 2023-11-15)
Primary citationHan, Q.,Robinson, H.,Li, J.
Crystal Structure of Human Kynurenine Aminotransferase II
J.Biol.Chem., 283:3567-3573, 2008
Cited by
PubMed Abstract: Human kynurenine aminotransferase II (hKAT-II) efficiently catalyzes the transamination of knunrenine to kynurenic acid (KYNA). KYNA is the only known endogenous antagonist of N-methyl-D-aspartate (NMDA) receptors and is also an antagonist of 7-nicotinic acetylcholine receptors. Abnormal concentrations of brain KYNA have been implicated in the pathogenesis and development of several neurological and psychiatric diseases in humans. Consequently, enzymes involved in the production of brain KYNA have been considered potential regulatory targets. In this article, we report a 2.16 A crystal structure of hKAT-II and a 1.95 A structure of its complex with kynurenine. The protein architecture of hKAT-II reveals that it belongs to the fold-type I pyridoxal 5-phosphate (PLP)-dependent enzymes. In comparison with all subclasses of fold-type I-PLP-dependent enzymes, we propose that hKAT-II represents a novel subclass in the fold-type I enzymes because of the unique folding of its first 65 N-terminal residues. This study provides a molecular basis for future effort in maintaining physiological concentrations of KYNA through molecular and biochemical regulation of hKAT-II.
PubMed: 18056995
DOI: 10.1074/jbc.M708358200
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.3 Å)
Structure validation

227344

PDB entries from 2024-11-13

PDB statisticsPDBj update infoContact PDBjnumon